Paper Diagnostics Market (2026 - 2033)

Paper Diagnostics Market Summary

The global paper diagnostics market size was valued at USD 16.9 billion in 2025 and is projected to grow from USD 17.9 billion in 2026 to USD 26.9 billion by 2033, at a CAGR of 6.0% from 2026 to 2033. North America dominated the industry with a revenue share of 34.5% in 2025. The increasing need for cost-effective healthcare in remote areas of developing countries is leading to the rising popularity of point-of-care diagnostic methods in these countries. Moreover, increased adoption of point-of-care diabetes and pregnancy test kits is projected to support market growth.

Changing lifestyle habits, including smoking and an unhealthy diet, coupled with an increased incidence of obesity, are anticipated to lead to an increase in the prevalence of lifestyle-associated diseases, such as diabetes and cardiac diseases, worldwide. For instance, as per the International Diabetes Federation (IDF), in 2024, around 589 million people were diagnosed with diabetes globally. In addition, about 11.1% of adults between 20 and 79 years of age have diabetes, and half of them are unaware of it. The burden is expected to increase substantially, with the number of adults living with diabetes projected to reach 853 million by 2050. Furthermore, in 2024, nearly 42.8% (i.e., 251.7 million) of adults with diabetes (20–79 years old) remain undiagnosed, highlighting the increasing demand for easily accessible screening and diagnostic devices worldwide.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The rising focus of established players in Japan on developing technologically advanced paper diagnostics, increasing healthcare initiatives, and clinical development frameworks of emerging economies are poised to create ample growth opportunities for the market in APAC. The rising incidence of hospital-acquired urinary tract infections in India is prompting hospitals and doctors to focus on the delivery of proper care and the incorporation of diagnostic techniques.

In addition, an urgent need for the development of new systems and replacing & upgrading medical infrastructure is also projected to positively influence the market during the forecast period. Furthermore, the presence of untapped opportunities in emerging economies such as India, China, and Brazil in the field of paper-based point-of-care diagnostics is anticipated to boost the growth of the market during the forecast period.

Paper diagnostics is considered to be one of the mature segments in the point-of-care market. The key characteristics of paper diagnostics, such as being inexpensive with high-performance and easily disposable, are the key growth determinants of the market. Numerous companies expressed their interest in developing paper diagnostics technology and gaining patents for the same. For instance, in June 2024, researchers at Purdue University developed a portable, paper-based biosensor that can detect fecal contamination on farm produce in less than an hour after sample collection. Such innovations are expected to support the adoption of paper diagnostics across healthcare, environmental monitoring, and food safety applications.

Analyst Perspective

The paper diagnostics market is expected to witness steady growth driven by the increasing demand for rapid, affordable, and user-friendly diagnostic solutions over the coming years. The increasing use of point-of-care testing devices and self-monitoring instruments is pushing clinicians and consumers toward decentralized diagnostics. Paper-based technology exhibits a low cost of manufacturing, is portable, easily disposable, with minimum infrastructural requirements, making it particularly suitable for resource-constrained settings. Further development of paper-based microfluidics and introduction of novel biomaterials and nanotechnology into the diagnostic platform will continue to boost development in the coming years. Companies are increasingly focusing on the manufacturing of paper-based diagnostic products of higher sensitivity and accuracy in clinical diagnostics, environmental testing, and food testing applications. As healthcare systems continue to emphasize early diagnosis and accessible testing, paper diagnostics are expected to remain an important component of the global diagnostic landscape.

Kit Type Insights

The lateral flow assays segment held the largest revenue share in 2025. The growth of the segment can be attributed to the wide usage rates of pregnancy tests and a wide range of applications of the product type. Furthermore, the growing incidence of infectious diseases such as human immunodeficiency virus (HIV), tuberculosis (TB), and pneumonia is estimated to spur the growth of the segment during the forecast period.

The paper-based microfluidics segment is expected to exhibit significant growth over the forecast period owing to surging demand for point-of-care testing and R&D investments by life sciences and pharmaceutical companies. For instance, researchers from Purdue University, U.S., developed "Self-powered and Paper-based Electrochemical Devices (SPEDs)," a portable paper-based device that can identify diseases such as anemia. It is a medical diagnostic device made of paper, which helps detect biomarkers and identify diseases by performing an electrochemical analysis.

Device Type Insights

The diagnostic devices held the largest revenue share in 2025. Paper diagnostic devices are used in blood separation and glucose detection. The rising awareness regarding associated merits, such as improved intensity, quality, and frequency of diagnosis, along with new product launches and approvals, is likely to supplement the growth of the segment.

Novel wax patterning technology can provide greater flexibility and adaptability, thereby increasing the potential of the diagnostics devices segment. Furthermore, the burgeoning popularity of programmable microfluidics devices in urinalysis is poised to augment the growth of the segment during the forecast period.

The monitoring devices segment is projected to record growth during the forecast period. This can be attributed to the increasing usage of these devices in various applications. The monitoring devices segment is projected to witness steady growth during the forecast period, driven by the increasing adoption of paper-based diagnostic technologies for point-of-care testing and disease monitoring. Growing demand for rapid, cost-effective, and user-friendly diagnostic solutions in healthcare settings is supporting the use of monitoring devices that enable quick interpretation and analysis of test results. Furthermore, the rising prevalence of infectious and chronic diseases, increasing healthcare expenditure, and expanding access to diagnostic services in emerging economies are expected to contribute to segment growth.

End-use Insights

The hospitals & clinics segment held the largest revenue share of around 45.5% in 2025, owing to the increasing demand for rapid and accurate diagnosis of various diseases. Paper diagnostics are low-cost, easy-to-use, and portable devices that can provide results within minutes without requiring sophisticated equipment or trained personnel. These technologies are increasingly being utilized for the diagnosis of infectious diseases such as tuberculosis, influenza, dengue, and STIs, along with screening and monitoring chronic conditions such as diabetes, cardiovascular diseases, and cancer. The capacity to be utilized as point-of-care tests and decentralized medicine delivery is further contributing to their growing adoption across hospitals and clinical settings.

The assisted living healthcare facilities segment is expected to grow at the fastest CAGR over the forecast period, which can be attributed to the increasing geriatric population and prevalence of chronic diseases. Frequent monitoring and early diagnosis of illness in the elderly population are becoming increasingly important, thus increasing the need for portable and economical diagnostic devices. Portability, simple operation, and fast readout times offered by paper-based diagnostics make them a suitable option. Preventive medicine, routine screening, and decentralized testing initiatives also stimulate the use of paper-based diagnostic devices in assisted living facilities.

Application Insights

The clinical diagnostics segment held the largest share in 2025, owing to the increasing usage of filter paper, microfluidics, and paper-based biosensors in diagnosing liver disorders. In addition, the segment is estimated to dominate the market throughout the forecast period owing to the increasing prevalence of infectious diseases such as Ebola, malaria, dengue, tuberculosis, and HIV. Moreover, new product launches and technological advancements are expected to support the segment's growth.

The segment is also expected to grow at a fast rate over the forecast period, primarily driven by the growing need for fast, economical, and point-of-care diagnostic technologies for early detection of several diseases. Paper-based diagnostic technologies are being widely used in clinical environments as they are mobile, easy to use, and give out results without the requirement for extensive laboratory setups.

Regional Insights

North America captured a major market share of approximately 34.5% in 2025. The region is expected to maintain a similar trend over the forecast period. This growth can be attributed to the presence of key market players, including academic and research institutes in the region, and the increasing incidence of infectious diseases. For instance, researchers across leading North American institutions continue to advance paper-based and point-of-care diagnostic technologies for rapid disease detection. These advancements in low-cost biosensors, microfluidic paper-based devices, and smartphone-integrated diagnostic platforms enhance ease of testing in both clinical and point-of-care environments. These innovations are facilitating wider use of paper diagnostics in the region and enhancing faster diagnosis, decreasing healthcare costs, and enhancing testing access to all communities.

To learn more about this report, Download Free Sample Report

Asia Pacific Paper Diagnostics Market Trends

The paper diagnostics market in Asia Pacific is projected to register the fastest CAGR over the forecast period, which can be a result of increasing investment in the healthcare sector, various government initiatives, education, and an increase in awareness about health. The Indian market is anticipated to register the fastest growth rate over the forecasted period; the key factors supporting the market growth are increasing demand for cost-effective diagnostic tools for the rural population and acceleration in product development through regional players.

Key Paper Diagnostics Companies Insights

The paper diagnostics market is characterized by the presence of several established healthcare and diagnostics companies that compete based on product innovation, test accuracy, ease of use, and geographic reach. Product launches, research partnerships, technological developments, and increasing market reach in developing markets continue to be the most dominant growth strategies among the leading players in the market.

Key Paper Diagnostics Companies

The following key companies have been profiled for this study on the paper diagnostics market:

• Arkray, Inc.

• Acon Laboratories, Inc.

• Abbott (Alere Inc.)

• Bio-Rad Laboratories, Inc.

• Gvs S.P.A.

• Siemens Healthcare GmbH

• Diagnostics For All, Inc.

• Ffei Life Science (Biognostix)

• Navigene

• Micro Essential Laboratory Inc.

• Kenosha Tapes

Recent Developments

• In March 2024, ARKRAY launched an automated rotating sample barcode reader for blood glucose measurement systems to improve workflow automation. The development strengthens ARKRAY's diabetes diagnostics ecosystem, supporting the broader adoption of blood glucose test strips and other paper-based diagnostic solutions used in point-of-care testing.

Paper Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global paper diagnostics market report based on kit type, device type, application, end-use, and region:

• Kit Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Lateral Flow Assays

  • Dipsticks

  • Paper Based Microfluidics

• Device Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Diagnostic Devices

  • Monitoring Devices

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Clinical Diagnostics

    • Cancer

    • Infectious Diseases

    • Liver Disorders

    • Others

  • Food Quality Testing

  • Environmental Monitoring

• End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Home Healthcare

  • Assisted Living Healthcare Facilities

  • Hospital and Clinics

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait